RCMI Coordinating Center (RCMI CC) Header Logo

Sheilah Clayton

Concepts (47)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Nurse's Role
1
2011
37
0.350
 Why?
Breast Neoplasms
5
2017
1723
0.320
 Why?
Clinical Trials as Topic
1
2011
259
0.310
 Why?
Minority Groups
1
2011
690
0.240
 Why?
Health Services Accessibility
1
2011
706
0.240
 Why?
Transforming Growth Factor beta
1
2017
216
0.120
 Why?
Survivors
1
2014
152
0.100
 Why?
Nurse-Patient Relations
1
2011
6
0.090
 Why?
Academic Medical Centers
1
2011
76
0.090
 Why?
Patient Participation
1
2011
94
0.080
 Why?
Patient Selection
1
2011
205
0.080
 Why?
California
1
2011
548
0.080
 Why?
Amino Acid Transport Systems
1
2006
5
0.060
 Why?
Paclitaxel
1
2006
64
0.060
 Why?
Amino Acids
1
2006
148
0.060
 Why?
Proto-Oncogene Proteins c-akt
1
2008
299
0.060
 Why?
Antineoplastic Agents, Phytogenic
1
2006
134
0.060
 Why?
Female
5
2017
24698
0.040
 Why?
Apoptosis
1
2006
1568
0.040
 Why?
Thiosemicarbazones
1
2017
10
0.030
 Why?
Humans
5
2017
43102
0.030
 Why?
Receptors, Transforming Growth Factor beta
1
2017
26
0.030
 Why?
beta Catenin
1
2017
78
0.030
 Why?
Pyrazoles
1
2017
103
0.030
 Why?
Vascular Endothelial Growth Factor A
1
2017
183
0.030
 Why?
Cell Line, Tumor
2
2017
2676
0.030
 Why?
Evidence-Based Medicine
1
2014
107
0.030
 Why?
Drug Resistance, Neoplasm
1
2017
307
0.030
 Why?
Data Collection
1
2014
210
0.030
 Why?
Gene Expression Regulation, Neoplastic
1
2017
968
0.020
 Why?
Disease-Free Survival
1
2008
116
0.020
 Why?
Ethylmaleimide
1
2006
8
0.020
 Why?
Starvation
1
2006
12
0.020
 Why?
Maleimides
1
2006
12
0.020
 Why?
Alanine
1
2006
34
0.020
 Why?
Survival Analysis
1
2008
368
0.020
 Why?
In Situ Nick-End Labeling
1
2006
138
0.020
 Why?
Antibiotics, Antineoplastic
1
2006
51
0.020
 Why?
Sodium
1
2006
102
0.020
 Why?
Caspases
1
2006
148
0.020
 Why?
Doxorubicin
1
2006
97
0.020
 Why?
Immunohistochemistry
1
2008
934
0.010
 Why?
Enzyme Inhibitors
1
2006
458
0.010
 Why?
Dose-Response Relationship, Drug
1
2006
1124
0.010
 Why?
Gene Expression Regulation
1
2006
1070
0.010
 Why?
Cell Proliferation
1
2006
1455
0.010
 Why?
Middle Aged
1
2008
12222
0.010
 Why?
Clayton's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (47)
Explore
_
Co-Authors (4)
Explore
_
Similar People (59)
Explore
_
Same Department Expand Description
Explore
_
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support